These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16451086)

  • 1. Evaluation of hydroxyimine as cytochrome P450-selective prodrug structure.
    Kumpulainen H; Mähönen N; Laitinen ML; Jaurakkajärvi M; Raunio H; Juvonen RO; Vepsäläinen J; Järvinen T; Rautio J
    J Med Chem; 2006 Feb; 49(3):1207-11. PubMed ID: 16451086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro characterization of the cytochrome P450 isoforms involved in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone.
    Matsumoto K; Nemoto E; Hasegawa T; Akimoto M; Sugibayashi K
    Biol Pharm Bull; 2011; 34(5):734-9. PubMed ID: 21532165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical power of LLE-HPLC-PDA-MS/MS in drug metabolism studies: identification of new nabumetone metabolites.
    Nobilis M; Mikušek J; Szotáková B; Jirásko R; Holčapek M; Chamseddin C; Jira T; Kučera R; Kuneš J; Pour M
    J Pharm Biomed Anal; 2013 Jun; 80():164-72. PubMed ID: 23584048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes.
    Matsumoto K; Hasegawa T; Ohara K; Takei C; Kamei T; Koyanagi J; Takahashi T; Akimoto M
    Xenobiotica; 2020 Jul; 50(7):783-792. PubMed ID: 31855101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of human flavin-containing monooxygenase (FMO) 5 in the metabolism of nabumetone: Baeyer-Villiger oxidation in the activation of the intermediate metabolite, 3-hydroxy nabumetone, to the active metabolite, 6-methoxy-2-naphthylacetic acid
    Matsumoto K; Hasegawa T; Ohara K; Kamei T; Koyanagi J; Akimoto M
    Xenobiotica; 2021 Feb; 51(2):155-166. PubMed ID: 33146575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel injection strategy of flurbiprofen axetil by inhibiting protein binding with 6-methoxy-2-naphthylacetic acid.
    Ogata K; Takamura N; Tokunaga J; Ikeda T; Setoguchi N; Tanda K; Yamasaki T; Nishio T; Kawai K
    Eur J Drug Metab Pharmacokinet; 2016 Apr; 41(2):179-86. PubMed ID: 25537338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon-carbon bond cleavage in activation of the prodrug nabumetone.
    Varfaj F; Zulkifli SN; Park HG; Challinor VL; De Voss JJ; Ortiz de Montellano PR
    Drug Metab Dispos; 2014 May; 42(5):828-38. PubMed ID: 24584631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of Piperazinylalkylester Prodrugs of 6-Methoxy-2-Naphthylacetic Acid (6-MNA) for Percutaneous Drug Delivery.
    Pawar V; Thosani R; Kanhed A; Giridhar R; Yadav MR
    AAPS PharmSciTech; 2015 Jun; 16(3):518-27. PubMed ID: 25370023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazen-1-ium-1,2-diolated and nitrooxyethyl nitric oxide donor ester prodrugs of anti-inflammatory (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic acids: synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Chen QH; Knaus EE
    Bioorg Med Chem; 2008 Mar; 16(6):3302-8. PubMed ID: 18096394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic ester prodrugs possessing a diazen-1-ium-1,2-diolate moiety: design, synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
    Abdellatif KR; Dong Y; Chen QH; Chowdhury MA; Knaus EE
    Bioorg Med Chem; 2007 Nov; 15(21):6796-801. PubMed ID: 17764958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ester Prodrugs of Ketoprofen: Synthesis, In Vitro Stability, In Vivo Biological Evaluation and In Silico Comparative Docking Studies Against COX-1 and COX-2.
    Ahmed M; Azam F; Gbaj A; Zetrini AE; Abodlal AS; Rghigh A; Elmahdi E; Hamza A; Salama M; Bensaber SM
    Curr Drug Discov Technol; 2016; 13(1):41-57. PubMed ID: 26785683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the antiinflammatory prodrug, nabumetone and its principal active metabolite on rat gastric mucosal, aortic and platelet eicosanoid synthesis, in vitro and ex vivo.
    Jeremy JY; Thompson CS; Mikhailidis DP; Dandona P
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):195-9. PubMed ID: 2281122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain uptake of ketoprofen-lysine prodrug in rats.
    Gynther M; Jalkanen A; Lehtonen M; Forsberg M; Laine K; Ropponen J; Leppänen J; Knuuti J; Rautio J
    Int J Pharm; 2010 Oct; 399(1-2):121-8. PubMed ID: 20727958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the xanthine derivative denbufylline and the anti-inflammatory agent nabumetone on microsomal free radical production and lipid peroxidation in rat liver.
    Barth A; Kaiser N; Löffler U; Sourgens H; Klinger W
    Exp Toxicol Pathol; 1994 Dec; 46(6):483-9. PubMed ID: 7703681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. V-PROLI/NO, a prodrug of the nitric oxide donor, PROLI/NO.
    Chakrapani H; Showalter BM; Kong L; Keefer LK; Saavedra JE
    Org Lett; 2007 Aug; 9(17):3409-12. PubMed ID: 17658755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Velázquez C; Das D; Suresh MR; Knaus EE
    Bioorg Med Chem; 2008 Nov; 16(22):9694-8. PubMed ID: 18930406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A photophysical and photochemical study of 6-methoxy-2-naphthylacetic acid, the major metabolite of the phototoxic nonsteroidal antiinflammatory drug nabumetone.
    Boscá F; Canudas N; Marín ML; Miranda MA
    Photochem Photobiol; 2000 Feb; 71(2):173-7. PubMed ID: 10687391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
    Bandgar BP; Sarangdhar RJ; Ahamed FA; Viswakarma S
    J Med Chem; 2011 Mar; 54(5):1202-10. PubMed ID: 21250699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
    Velázquez CA; Chen QH; Citro ML; Keefer LK; Knaus EE
    J Med Chem; 2008 Mar; 51(6):1954-61. PubMed ID: 18314945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New prodrugs of the antiprotozoal drug pentamidine.
    Kotthaus J; Kotthaus J; Schade D; Schwering U; Hungeling H; Müller-Fielitz H; Raasch W; Clement B
    ChemMedChem; 2011 Dec; 6(12):2233-42. PubMed ID: 21984033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.